Kynteles Injection: Uses, Benefits, Side Effects

Kynteles Injection (Vedolizumab 300 mg) is a prescription biologic medicine used in the treatment of specific inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease. Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information and international supply assistance for healthcare professionals, distributors, importers and other eligible pharmaceutical buyers.

Product Description: Kynteles Injection

Kynteles Injection contains vedolizumab, a monoclonal antibody that selectively targets the alpha-4 beta-7 (α4β7) integrin involved in the movement of certain immune cells into the intestinal tissues. By reducing this process, vedolizumab helps control inflammation associated with inflammatory bowel disease.

Product details:

Brand Name: Kynteles Injection

Generic Name: Vedolizumab

Common Strength: 300 mg

Dosage Form: Powder for concentrate for solution for intravenous infusion

Therapeutic Category: Biologic immunomodulator

Primary Indications: Ulcerative colitis and Crohn’s disease

Administration: Intravenous infusion by qualified healthcare professionals

Prescription Status: Prescription medicine

Product strength, presentation, availability and approved indications should be confirmed against the current product packaging and applicable local regulatory requirements.

Benefits and Uses of Kynteles Injection

1. Ulcerative Colitis Management

Kynteles Injection may be prescribed for eligible patients with moderately to severely active ulcerative colitis. By targeting inflammation in the digestive tract, vedolizumab can help improve symptoms and support clinical remission.

2. Crohn’s Disease Treatment

For appropriate patients with moderately to severely active Crohn’s disease, vedolizumab can help reduce intestinal inflammation and improve disease control. Treatment response varies according to individual circumstances.

3. Targeted Biological Action

Vedolizumab selectively targets immune-cell trafficking into the gut. This mechanism differs from that of medicines that suppress immune activity more broadly throughout the body.

4. Support for Long-Term Disease Management

When effective and prescribed as part of an appropriate treatment plan, Kynteles Injection may help maintain disease control. Regular medical assessment is important to monitor effectiveness and treatment safety.

Kynteles Injection is not a guaranteed cure. Its suitability and expected benefits must be assessed by a qualified gastroenterologist.

Possible Side Effects of Kynteles Injection

Like other biologic medicines, Kynteles Injection may cause side effects. Reported effects include:

Headache

Joint pain

Nasopharyngitis (inflammation of the nose and throat)

Upper respiratory tract infections

Nausea

Fatigue

Fever

Infusion-related reactions

Serious risks can include severe infections and significant allergic or infusion reactions. Patients should seek urgent medical attention for breathing difficulties, facial or throat swelling, or other severe symptoms.

Before treatment, patients should inform their healthcare professional about existing infections, tuberculosis risk, previous allergic reactions, vaccinations, pregnancy or breastfeeding, and all medicines they use. Appropriate screening and monitoring are essential.

Disclaimer: This information is for educational purposes only and does not replace the approved prescribing information or professional medical advice. Kynteles Injection must be used only under appropriate medical supervision.

Frequently Asked Questions (FAQs)

1. What is Kynteles Injection used for?

Kynteles Injection contains vedolizumab and is used to treat certain patients with ulcerative colitis and Crohn’s disease, according to the approved local prescribing information.

2. What is the strength of Kynteles Injection?

A commonly marketed presentation is 300 mg. Confirm the exact strength and packaging with the supplier before placing an order.

3. How is Kynteles Injection administered?

The 300 mg intravenous formulation is administered as an infusion by a qualified healthcare professional according to the prescribed treatment schedule.

4. What are the common side effects of Kynteles Injection?

Headache, joint pain, nausea, fatigue and upper respiratory symptoms are among the reported side effects. Serious or persistent symptoms require medical evaluation.

5. How can international buyers enquire about Kynteles Injection?

Eligible pharmaceutical importers, distributors and healthcare procurement teams can contact Cordium Pharmaceuticals Pvt Ltd to enquire about product availability, documentation, export requirements and destination-country regulations.

Contact Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd, based in Nagpur, Maharashtra, India, supports pharmaceutical trade and international buyer enquiries.